Cargando…

Application of cross-species PET imaging to assess neurotransmitter release in brain

RATIONALE: This review attempts to summarize the current status in relation to the use of positron emission tomography (PET) imaging in the assessment of synaptic concentrations of endogenous mediators in the living brain. OBJECTIVES: Although PET radioligands are now available for more than 40 CNS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Finnema, Sjoerd J., Scheinin, Mika, Shahid, Mohammed, Lehto, Jussi, Borroni, Edilio, Bang-Andersen, Benny, Sallinen, Jukka, Wong, Erik, Farde, Lars, Halldin, Christer, Grimwood, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600473/ https://www.ncbi.nlm.nih.gov/pubmed/25921033 http://dx.doi.org/10.1007/s00213-015-3938-6

Ejemplares similares

Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
por: Yang, Kai-Chun, et al.
Publicado: (2016)

Amphetamine Decreases α(2C)-Adrenoceptor Binding of [(11)C]ORM-13070: A PET Study in the Primate Brain
por: Finnema, Sjoerd J, et al.
Publicado: (2015)

Serotonin concentration enhancers at clinically relevant doses reduce [(11)C]AZ10419369 binding to the 5-HT(1B) receptors in the nonhuman primate brain
por: Yang, Kai-Chun, et al.
Publicado: (2018)

Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates
por: Schou, Magnus, et al.
Publicado: (2015)

Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo
por: Varnäs, Katarina, et al.
Publicado: (2021)

Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [(18)F]Lu AF10628
por: Varnäs, Katarina, et al.
Publicado: (2016)

PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [(18)F]GEH200449 for Detection of Monoamine Oxidase-B in the Non-Human Primate Brain
por: Varnäs, Katarina, et al.
Publicado: (2023)

Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
por: Yang, Kai-Chun, et al.
Publicado: (2017)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

Comparison of D(2) dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects
por: Nord, Magdalena, et al.
Publicado: (2011)

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator
por: Schou, Magnus, et al.
Publicado: (2019)

High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
por: Fazio, Patrik, et al.
Publicado: (2020)

PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018)

Imaging of α2C-adrenoceptors in the living brain: a method to monitor noradrenaline release?
por: Scheinin, Mika, et al.
Publicado: (2015)

ABC transporter-dependent brain uptake of the 5-HT(1B) receptor radioligand [(11)C]AZ10419369: a comparative PET study in mouse, rat, and guinea pig
por: Tóth, Miklós, et al.
Publicado: (2014)

Application of the PET ligand [(11)C]ORM-13070 to examine receptor occupancy by the α(2C)-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain
por: Shahid, Mohammed, et al.
Publicado: (2020)

Potential for imaging the high-affinity state of the 5-HT(1B) receptor: a comparison of three PET radioligands with differing intrinsic activity
por: Lindberg, Anton, et al.
Publicado: (2019)

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
por: Stenkrona, Per, et al.
Publicado: (2019)

Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012)

Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[(11) C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([(11) C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1
por: Fuchigami, Takeshi, et al.
Publicado: (2012)

Neurotransmitter release /
Publicado: (1999)

[(11)C]SCH23390 binding to the D(1)-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis
por: Stenkrona, Per, et al.
Publicado: (2018)

Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: (18)F-AZD9272
por: Nag, Sangram, et al.
Publicado: (2020)

Serotonin transporter availability in adults with autism—a positron emission tomography study
por: Andersson, Max, et al.
Publicado: (2020)

Decreased 5‐HT(1A) binding in mild Alzheimer's disease—A positron emission tomography study
por: Mattsson, Patrik, et al.
Publicado: (2022)

GABA(A) receptor occupancy by subtype selective GABA(Aα2,3) modulators: PET studies in humans
por: Jucaite, Aurelija, et al.
Publicado: (2016)

PET technology for drug development in psychiatry
por: Arakawa, Ryosuke, et al.
Publicado: (2020)

Three-dimensional versus two-dimensional high-definition laparoscopy in cholecystectomy: a prospective randomized controlled study
por: Koppatz, Hanna, et al.
Publicado: (2019)

Effects of amphetamine on the human brain opioid system – a positron emission tomography study
por: Guterstam, Joar, et al.
Publicado: (2013)

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

The self-regulation of neurotransmitter release
por: Canepari, Marco
Publicado: (2014)

Synthesis and Autoradiography of Novel F-18 Labeled Reversible Radioligands for Detection of Monoamine Oxidase B
por: Nag, Sangram, et al.
Publicado: (2020)

Presenilins are Essential for Regulating Neurotransmitter Release
por: Zhang, Chen, et al.
Publicado: (2009)

Genetic disorders of neurotransmitter release machinery
por: Uzay, Burak, et al.
Publicado: (2023)

A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques
por: Yamanaka, H, et al.
Publicado: (2014)

PET as a Translational Tool in Drug Development for Neuroscience Compounds
por: Varrone, Andrea, et al.
Publicado: (2022)

Dealing with PET radiometabolites
por: Ghosh, Krishna Kanta, et al.
Publicado: (2020)

Low background and high contrast PET imaging of amyloid-β with [(11)C]AZD2995 and [(11)C]AZD2184 in Alzheimer’s disease patients
por: Forsberg, Anton, et al.
Publicado: (2013)

Chemical delivery array with millisecond neurotransmitter release
por: Jonsson, Amanda, et al.
Publicado: (2016)

Dynamic Control of Neurotransmitter Release by Presynaptic Potential
por: Zbili, Mickael, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3jc1j1lehk3hu2kocgb4i5al1b